{"transactions":[{"id":758768,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-29T21:01:13.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":49417,"source":{"system":"sec-edgar","filing":"0001171843-26-003800","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000117184326003800/ownership.xml","form_type":"4"}},{"id":1127762,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-03T01:24:36.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":20001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date."}],"balance_after":30417,"source":{"system":"sec-edgar","filing":"0001171843-25-003591","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000117184325003591/ownership.xml","form_type":"4"}},{"id":1267457,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-02-14T22:02:30.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":10416,"price":1.92,"value":19998.72,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 12, 2025, the Reporting Person purchased in a private placement, 10,416 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share."}],"balance_after":10416,"source":{"system":"sec-edgar","filing":"0001171843-25-000869","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000117184325000869/ownership.xml","form_type":"4"}},{"id":1824188,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-24T20:46:03.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2033-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009599","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495423009599/section16.xml","form_type":"4/A","original_submission_date":"2023-07-21"}},{"id":1824887,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Share Option (right to buy)","published_at":"2023-07-21T20:30:18.000Z","date":"2023-07-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.8277,"expiration_date":"2023-07-20","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-23-009527","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495423009527/section16.xml","form_type":"4"}},{"id":2348090,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-03-08T00:40:39.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the Grant Date."}],"balance_after":11000,"derivative":{"exercise_price":3.71,"expiration_date":"2032-02-28","underlying":"Common Shares","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001654954-22-002654","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495422002654/section16.xml","form_type":"4"}},{"id":2739701,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2021-04-26T20:53:51.000Z","date":"2021-04-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 12 months beginning on the Grant Date."}],"balance_after":20000,"derivative":{"exercise_price":5.45,"expiration_date":"2031-04-22","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-21-004626","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495421004626/section16.xml","form_type":"4"}},{"id":2989873,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-11-06T15:04:14.000Z","date":"2020-11-05","kind":"other","acquired":false,"shares":1218,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"York-Cav Enterprises, Inc. is partially owned by the reporting party.  Mr. Sistilli disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common shares","underlying_shares":1218},"source":{"system":"sec-edgar","filing":"0001654954-20-011927","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420011927/section16.xml","form_type":"4"}},{"id":2989872,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Common shares","published_at":"2020-11-06T15:04:14.000Z","date":"2020-11-05","kind":"other","acquired":true,"shares":1218,"price":4,"value":4872.0,"ownership":{"direct":false,"nature":"Held by York-Cav Enterprises, Inc."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"York-Cav Enterprises, Inc. is partially owned by the reporting party.  Mr. Sistilli disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":3654,"source":{"system":"sec-edgar","filing":"0001654954-20-011927","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420011927/section16.xml","form_type":"4"}},{"id":3007326,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2020-10-14T19:57:26.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly in equal proportions over 36 months beginning on the Grant Date."}],"balance_after":20000,"derivative":{"exercise_price":7.44,"expiration_date":"2030-10-13","underlying":"Common shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001654954-20-011152","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420011152/section16.xml","form_type":"4"}},{"id":3270877,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Share Option (Right to Buy)","published_at":"2020-02-14T23:08:36.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":11389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested"}],"balance_after":11389,"derivative":{"exercise_price":3.16,"expiration_date":"2030-02-12","underlying":"Common Shares","underlying_shares":11389},"source":{"system":"sec-edgar","filing":"0001654954-20-001647","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420001647/section16.xml","form_type":"4"}},{"id":3312669,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-13T13:30:55.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":1218,"ownership":{"direct":false,"nature":"Held by York-Cav Enterprises, Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"York-Cav Enterprises, Inc. is partially owned by the reporting party.Mr. Sistilli disclaims beneficial ownership except to the extent of his precautionary interest therein."}],"balance_after":1218,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":1218},"source":{"system":"sec-edgar","filing":"0001654954-20-000336","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420000336/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3312668,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-13T13:30:55.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":1827,"ownership":{"direct":false,"nature":"Held by York-Cav Enterprises, Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"York-Cav Enterprises, Inc. is partially owned by the reporting party.Mr. Sistilli disclaims beneficial ownership except to the extent of his precautionary interest therein."}],"balance_after":1827,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":1827},"source":{"system":"sec-edgar","filing":"0001654954-20-000336","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420000336/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3312667,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Common Shares","published_at":"2020-01-13T13:30:55.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":2436,"price":4.11,"value":10011.96,"ownership":{"direct":false,"nature":"Held by York-Cav Enterprises, Inc."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Amended to reflect acquisition from the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"York-Cav Enterprises, Inc. is partially owned by the reporting party.Mr. Sistilli disclaims beneficial ownership except to the extent of his precautionary interest therein."}],"balance_after":2436,"source":{"system":"sec-edgar","filing":"0001654954-20-000336","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420000336/section16.xml","form_type":"4/A","original_submission_date":"2020-01-10"}},{"id":3313680,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T19:13:12.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":1218,"ownership":{"direct":false,"nature":"Held by York-Cav Enterprises, Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"York-Cav Enterprises, Inc. is partially owned by the reporting party.Mr. Sistilli disclaims beneficial ownership except to the extent of his precautionary interest therein."}],"balance_after":1218,"derivative":{"exercise_price":4,"exercise_date":"2020-07-08","expiration_date":"2020-11-08","underlying":"Common Shares","underlying_shares":1218},"source":{"system":"sec-edgar","filing":"0001654954-20-000269","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420000269/section16.xml","form_type":"4"}},{"id":3313679,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Common Share Warrants (Right to Buy)","published_at":"2020-01-10T19:13:12.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":1827,"ownership":{"direct":false,"nature":"Held by York-Cav Enterprises, Inc."},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"York-Cav Enterprises, Inc. is partially owned by the reporting party.Mr. Sistilli disclaims beneficial ownership except to the extent of his precautionary interest therein."}],"balance_after":1827,"derivative":{"exercise_price":4.8,"exercise_date":"2020-07-08","expiration_date":"2023-07-08","underlying":"Common Shares","underlying_shares":1827},"source":{"system":"sec-edgar","filing":"0001654954-20-000269","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420000269/section16.xml","form_type":"4"}},{"id":3313678,"issuer":{"id":7223,"kind":"organization","name":"Edesa Biotech, Inc.","symbol":"EDSA"},"owners":[{"id":43181,"kind":"person","name":"Sistilli Carlo","position":1,"cik":"0001777988","reported_name":"Sistilli Carlo","relationship":{"director":true}}],"security":"Common Shares","published_at":"2020-01-10T19:13:12.000Z","date":"2020-01-08","kind":"purchase","acquired":true,"shares":2436,"price":4.11,"value":10011.96,"ownership":{"direct":false,"nature":"Held by York-Cav Enterprises, Inc."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 2,436 Common Shares purchased by the reporting person for $4.11 per Common Share.  Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"York-Cav Enterprises, Inc. is partially owned by the reporting party.Mr. Sistilli disclaims beneficial ownership except to the extent of his precautionary interest therein."}],"balance_after":2436,"source":{"system":"sec-edgar","filing":"0001654954-20-000269","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1777988/000165495420000269/section16.xml","form_type":"4"}}]}